The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Swine Vaccines-Global Market Insights and Sales Trends 2025

Swine Vaccines-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1824515

No of Pages : 112

Ask Your Query
Synopsis
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
The global Swine Vaccines market size is expected to reach US$ 1820.9 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Swine Vaccines in various end use industries. The expanding demands from the Government Tender and Market Sales, are propelling Swine Vaccines market. CSF Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the FMD Vaccines segment is estimated at % CAGR for the next seven-year period.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Swine Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Swine Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Swine Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Swine Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Swine Vaccines covered in this report include Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio and Chopper Biology, etc.
The global Swine Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Global Swine Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Swine Vaccines market, Segment by Type:
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
Global Swine Vaccines market, by Application
Government Tender
Market Sales
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Swine Vaccines Market Overview
1.1 Swine Vaccines Product Overview
1.2 Swine Vaccines Market Segment by Type
1.2.1 CSF Vaccines
1.2.2 FMD Vaccines
1.2.3 Porcine Circovirus Vaccines
1.2.4 PRRS Vaccines
1.2.5 Others
1.3 Global Swine Vaccines Market Size by Type
1.3.1 Global Swine Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Swine Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Swine Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Swine Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Swine Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Swine Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Swine Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Swine Vaccines Sales Breakdown by Type (2018-2023)
2 Global Swine Vaccines Market Competition by Company
2.1 Global Top Players by Swine Vaccines Sales (2018-2023)
2.2 Global Top Players by Swine Vaccines Revenue (2018-2023)
2.3 Global Top Players by Swine Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Swine Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Swine Vaccines Market Competitive Situation and Trends
2.5.1 Swine Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Swine Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Swine Vaccines Market
2.8 Key Manufacturers Swine Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Swine Vaccines Status and Outlook by Region
3.1 Global Swine Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Swine Vaccines Historic Market Size by Region
3.2.1 Global Swine Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Swine Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Swine Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Swine Vaccines Forecasted Market Size by Region
3.3.1 Global Swine Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Swine Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Swine Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Swine Vaccines by Application
4.1 Swine Vaccines Market Segment by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Swine Vaccines Market Size by Application
4.2.1 Global Swine Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Swine Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Swine Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Swine Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Swine Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Swine Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Swine Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Swine Vaccines Sales Breakdown by Application (2018-2023)
5 North America Swine Vaccines by Country
5.1 North America Swine Vaccines Historic Market Size by Country
5.1.1 North America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Swine Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Swine Vaccines Sales in Value by Country (2018-2023)
5.2 North America Swine Vaccines Forecasted Market Size by Country
5.2.1 North America Swine Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Swine Vaccines Sales in Value by Country (2024-2029)
6 Europe Swine Vaccines by Country
6.1 Europe Swine Vaccines Historic Market Size by Country
6.1.1 Europe Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Swine Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Swine Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Swine Vaccines Forecasted Market Size by Country
6.2.1 Europe Swine Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Swine Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Swine Vaccines by Region
7.1 Asia-Pacific Swine Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Swine Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Swine Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Swine Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Swine Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Swine Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Swine Vaccines Sales in Value by Region (2024-2029)
8 Latin America Swine Vaccines by Country
8.1 Latin America Swine Vaccines Historic Market Size by Country
8.1.1 Latin America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Swine Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Swine Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Swine Vaccines Forecasted Market Size by Country
8.2.1 Latin America Swine Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Swine Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Swine Vaccines by Country
9.1 Middle East and Africa Swine Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Swine Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Swine Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Swine Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Swine Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Swine Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Swine Vaccines Products Offered
10.1.5 Merck Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Swine Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Jinyu Bio-Technology
10.3.1 Jinyu Bio-Technology Company Information
10.3.2 Jinyu Bio-Technology Introduction and Business Overview
10.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Jinyu Bio-Technology Swine Vaccines Products Offered
10.3.5 Jinyu Bio-Technology Recent Development
10.4 CAHIC
10.4.1 CAHIC Company Information
10.4.2 CAHIC Introduction and Business Overview
10.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CAHIC Swine Vaccines Products Offered
10.4.5 CAHIC Recent Development
10.5 Tecon
10.5.1 Tecon Company Information
10.5.2 Tecon Introduction and Business Overview
10.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Tecon Swine Vaccines Products Offered
10.5.5 Tecon Recent Development
10.6 Zoetis
10.6.1 Zoetis Company Information
10.6.2 Zoetis Introduction and Business Overview
10.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Zoetis Swine Vaccines Products Offered
10.6.5 Zoetis Recent Development
10.7 Ceva
10.7.1 Ceva Company Information
10.7.2 Ceva Introduction and Business Overview
10.7.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ceva Swine Vaccines Products Offered
10.7.5 Ceva Recent Development
10.8 Hile Bio
10.8.1 Hile Bio Company Information
10.8.2 Hile Bio Introduction and Business Overview
10.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hile Bio Swine Vaccines Products Offered
10.8.5 Hile Bio Recent Development
10.9 Chopper Biology
10.9.1 Chopper Biology Company Information
10.9.2 Chopper Biology Introduction and Business Overview
10.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Chopper Biology Swine Vaccines Products Offered
10.9.5 Chopper Biology Recent Development
10.10 WINSUN
10.10.1 WINSUN Company Information
10.10.2 WINSUN Introduction and Business Overview
10.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 WINSUN Swine Vaccines Products Offered
10.10.5 WINSUN Recent Development
10.11 Hipra
10.11.1 Hipra Company Information
10.11.2 Hipra Introduction and Business Overview
10.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hipra Swine Vaccines Products Offered
10.11.5 Hipra Recent Development
10.12 Ringpu Biology
10.12.1 Ringpu Biology Company Information
10.12.2 Ringpu Biology Introduction and Business Overview
10.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Ringpu Biology Swine Vaccines Products Offered
10.12.5 Ringpu Biology Recent Development
10.13 ChengDu Tecbond
10.13.1 ChengDu Tecbond Company Information
10.13.2 ChengDu Tecbond Introduction and Business Overview
10.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 ChengDu Tecbond Swine Vaccines Products Offered
10.13.5 ChengDu Tecbond Recent Development
10.14 DHN
10.14.1 DHN Company Information
10.14.2 DHN Introduction and Business Overview
10.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 DHN Swine Vaccines Products Offered
10.14.5 DHN Recent Development
10.15 CAVAC
10.15.1 CAVAC Company Information
10.15.2 CAVAC Introduction and Business Overview
10.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 CAVAC Swine Vaccines Products Offered
10.15.5 CAVAC Recent Development
10.16 Virbac
10.16.1 Virbac Company Information
10.16.2 Virbac Introduction and Business Overview
10.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Virbac Swine Vaccines Products Offered
10.16.5 Virbac Recent Development
10.17 HVRI
10.17.1 HVRI Company Information
10.17.2 HVRI Introduction and Business Overview
10.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 HVRI Swine Vaccines Products Offered
10.17.5 HVRI Recent Development
10.18 Bioveta
10.18.1 Bioveta Company Information
10.18.2 Bioveta Introduction and Business Overview
10.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Bioveta Swine Vaccines Products Offered
10.18.5 Bioveta Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Swine Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Swine Vaccines Industrial Chain Analysis
11.4 Swine Vaccines Market Dynamics
11.4.1 Swine Vaccines Industry Trends
11.4.2 Swine Vaccines Market Drivers
11.4.3 Swine Vaccines Market Challenges
11.4.4 Swine Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Swine Vaccines Distributors
12.3 Swine Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock